Azithromycin for Child Survival in Niger II
NCT06358872
Antimicrobial Resistance, Mortality
Niamey, Niger
View Trial DetailsNCT Number: NCT07234331
This study aims to model the relationship between the prevalence of ESBL-E and CPE carriage among nursing home residents and their respective concentrations in wastewater discharged from the facility.
Interested in participating?
Request Info18 year and older
All sexes
Observational
CHU d'Angers, Angers, France
Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) are now endemic in France, complicating the management of infections. In parallel, carbapenemase-producing Enterobacterales (CPE) are exhibiting rapid growth, necessitating enhanced surveillance systems and preventive measures across the healthcare network.
Current antimicrobial resistance (AMR) surveillance systems, which rely primarily on clinical samples, underestimate the dissemination of commensal bacteria and therefore limit the ability to anticipate epidemic events.
Transmission of ESBL-PE and CPE has been documented in long-term care facilities (LTCFs), where they may play a significant role in amplifying and maintaining outbreaks within the healthcare network. However, no dedicated surveillance system currently exists in these facilities.
The current French national strategy is based on standard precautions, but improved detection and identification of ESBL-PE and CPE in LTCFs could enable more effective prevention of transmission and reduce control-related costs.
The primary objective of this study is to model the relationship between the prevalence of ESBL-PE and CPE carriage among LTCF residents and their respective concentrations in facility wastewater effluents.
The primary outcome measure will be the fit and predictive performance of the model for estimating the prevalence of ESBL-PE/CPE carriage among LTCF residents. Carriage prevalence will be assessed through stool sampling or, when unavailable, rectal swabbing. The explanatory variable will be the quantification of ESBL-PE/CPE or resistance genes in wastewater effluents discharged from the LTCF during the corresponding study period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Residents may be included regardless of the presence of infection, diarrheal stools, antibiotic use or any other treatment, or health status.
Participants in this study may participate in other research projects concurrently.
Exclusion criteria
Health and medico-social facilities not considered nursing homes (e.g., FAM, MAS, etc.);
Time frame: 15 months
The primary endpoint will be the adequacy and predictive performance of the model for estimating the prevalence of ESBL-E/CPE carriage among nursing home residents. Carriage prevalence will be measured by collecting stool samples from residents or, failing that, by anorectal swabs.
Time frame: 15 months
To assess the prevalence of residents carrying ESBL and CPE in the population of nursing home residents in Loire-Atlantique and Maine-et-Loire
Nantes University Hospital
Other
Multicentre Study Analysing Wastewater to Monitor Bacterial Resistance to Antibiotics in Residential Care Homes for Elderly Dependent.
Acronym: E-FLUENT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06358872
Antimicrobial Resistance, Mortality
Niamey, Niger
View Trial DetailsNCT07684300
Antimicrobial Resistance, Antimicrobial Stewardship Program
Elche, Alicante, Spain
View Trial DetailsNCT06566898
Antimicrobial Resistance, Infections
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06436690
Antimicrobial Resistance
University Park, Pennsylvania, United States
View Trial Details